YO-T2D is secondary to both insulin resistance, in the liver, adipose tissue and peripheral tissues, and now increasingly recognized secondary to pancreatic β-cell dysfunction leading to reduced insulin production over time, and consequent relative insulin deficiency [36]. This evidence concerns the gene INS and Insulin resistance.